Your browser doesn't support javascript.
loading
Selective inhibition of phosphodiesterases 4, 5 and 9 induces HSP20 phosphorylation and attenuates amyloid beta 1-42-mediated cytotoxicity.
Cameron, Ryan T; Whiteley, Ellanor; Day, Jon P; Parachikova, Anna I; Baillie, George S.
Afiliação
  • Cameron RT; Institute of Cardiovascular and Medical Sciences College of Veterinary Medical and Life Sciences University of Glasgow UK.
  • Whiteley E; Institute of Cardiovascular and Medical Sciences College of Veterinary Medical and Life Sciences University of Glasgow UK.
  • Day JP; Institute of Cardiovascular and Medical Sciences College of Veterinary Medical and Life Sciences University of Glasgow UK.
  • Parachikova AI; Synaptic Transmission H. Lundbeck A/S Valby Denmark.
  • Baillie GS; Institute of Cardiovascular and Medical Sciences College of Veterinary Medical and Life Sciences University of Glasgow UK.
FEBS Open Bio ; 7(1): 64-73, 2017 Jan.
Article em En | MEDLINE | ID: mdl-28097089
Phosphodiesterase (PDE) inhibitors are currently under evaluation as agents that may facilitate the improvement of cognitive impairment associated with Alzheimer's disease. Our aim was to determine whether inhibitors of PDEs 4, 5 and 9 could alleviate the cytotoxic effects of amyloid beta 1-42 (Aß1-42) via a mechanism involving the small heatshock protein HSP20. We show that inhibition of PDEs 4, 5 and 9 but not 3 induces the phosphorylation of HSP20 which, in turn, increases the colocalisation between the chaperone and Aß1-42 to significantly decrease the toxic effect of the peptide. We conclude that inhibition of PDE9 is most effective to combat Aß1-42 cytotoxicity in our cell model.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: FEBS Open Bio Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: FEBS Open Bio Ano de publicação: 2017 Tipo de documento: Article